Joel S. Raichlen

7.3k citations

68 papers · 5.4k indexed · 3 hit papers · h-index 30

Surgery top 0.5%
Cardiology and Cardiovascular Medicine top 1%
Radiology, Nuclear Medicine and Imaging top 0.5%
Pulmonary and Respiratory Medicine top 2%
Endocrinology, Diabetes and Metabolism top 1%

Co-authors: Christie M. Ballantyne Stephen J. Nicholls Steven E. Nissen Peter Libby Valerie A. Cain Kathy Wolski Raimund Erbel Jean‐Claude Tardif
Topics: Lipoproteins and Cardiovascular Health (30 papers)Cardiac Imaging and Diagnostics (19 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers)
Cited by: Cardiology and Cardiovascular Medicine Surgery Radiology, Nuclear Medicine and Imaging
Journals: New England Journal of Medicine JAMA Circulation
Partner nations: United States Netherlands United Kingdom

In The Last Decade

Joel S. Raichlen

64 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis

2006 1.5k citations Steven E. Nissen, Stephen J. Nicholls et al. profile →
Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

2011 644 citations Stephen J. Nicholls, Christie M. Ballantyne et al. profile →
Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals With Subclinical Atherosclerosis

2007 510 citations John R. Crouse, Joel S. Raichlen et al. profile →

Peers

Countries citing papers authored by Joel S. Raichlen

Since Specialization

Citations

This map shows the geographic impact of Joel S. Raichlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel S. Raichlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel S. Raichlen more than expected).

Fields of papers citing papers by Joel S. Raichlen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel S. Raichlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel S. Raichlen. The network helps show where Joel S. Raichlen may publish in the future.

Co-authorship network of co-authors of Joel S. Raichlen

This figure shows the co-authorship network connecting the top 25 collaborators of Joel S. Raichlen. A scholar is included among the top collaborators of Joel S. Raichlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel S. Raichlen. Joel S. Raichlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations 2017 ·Journal of the American College of Cardiology ·Evan A. Stein,Eldad J. Dann,Albert Wiegman,Flemming Skovby,Daniel Gaudet,Étienne Sokal,Min‐Ji Charng,Mafauzy Mohamed,Ilse K. Luirink,Joel S. Raichlen,(unknown),Stefan Carlsson,Frederick J. Raal,John J.P. Kastelein	36
2	Sex-Related Differences of Coronary Atherosclerosis Regression Following Maximally Intensive Statin Therapy 2014 ·JACC. Cardiovascular imaging ·Rishi Puri,Steven E. Nissen,Mingyuan Shao,Christie M. Ballantyne,P.J. Barter,M. John Chapman,Raimund Erbel,Peter Libby,Joel S. Raichlen,Kiyoko Uno,Yu Kataoka,Stephen J. Nicholls	41
3	EFFECT OF ROSUVASTATIN THERAPY ON ARTERIAL WALL CHANGES IN CHILDREN AND ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE CHARON STUDY 2014 ·Journal of the American College of Cardiology ·Gisle Langslet,Marjet J.A.M. Braamskamp,Brian W. McCrindle,David Cassiman,Gordon Francis,Claude Gagné,Daniel Gaudet,Katherine M. Morrison,Albert Wiegman,Traci Turner,Elinor Miller,Joel S. Raichlen,Paula Martin,Evan A. Stein,John J.P. Kastelein	2
4	EFFICACY AND SAFETY OF ROSUVASTATIN THERAPY FOR CHILDREN AND ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE CHARON STUDY 2014 ·Journal of the American College of Cardiology ·Gisle Langslet,Marjet J.A.M. Braamskamp,Brian W. McCrindle,David Cassiman,Gordon A. Francis,Claude Gagné,Daniel Gaudet,Katherine M. Morrison,Albert Wiegman,Traci Turner,Elinor Miller,Joel S. Raichlen,Paula Martin,Paul Martin,Evan A. Stein,J. Kastelein	0
5	Factors underlying regression of coronary atheroma with potent statin therapy 2013 ·European Heart Journal ·Rishi Puri,Steven E. Nissen,Christie M. Ballantyne,P.J. Barter,M. John Chapman,Raimund Erbel,Peter Libby,Joel S. Raichlen,Julie St. John,Kathy Wolski,Kiyoko Uno,Yu Kataoka,Stephen J. Nicholls	59
6	Effect of Rosuvastatin on the Echolucency of the Common Carotid Intima-Media in Low-Risk Individuals: The METEOR Trial 2012 ·Journal of the American Society of Echocardiography ·Lars Lind,Sanne A. E. Peters,Hester M. den Ruijter,Mike K. Palmer,Diederick E. Grobbee,John R. Crouse,Daniel H. O’Leary,Gregory W. Evans,Joel S. Raichlen,Michiel L. Bots	19
7	SPECTROSCOPIC DETECTION OF FIBROUS CAP THICKNESS OVERLYING LIPID CORE CORONARY PLAQUES WITH A CATHETER-BASED NEAR-INFRARED SPECTROSCOPY SYSTEM 2012 ·Journal of the American College of Cardiology ·Sean Madden,Joel S. Raichlen,James E. Muller	3
8	REGRESSION OF CORONARY ATHEROMA VOLUME IN PATIENTS RECEIVING HIGH DOSE STATIN THERAPY: ANALYSIS OF THE SATURN STUDY 2012 ·Journal of the American College of Cardiology ·Stephen J. Nicholls,Christie M. Ballantyne,P.J. Barter,M. John Chapman,Raimund Erbel,Peter Libby,Joel S. Raichlen,Kiyoko Uno,Rishi Puri,Yu Kataoka,Kathy Wolski,Steven E. Nissen	0
9	Noninvasive LV Pressure Estimation Using Subharmonic Emissions From Microbubbles 2012 ·JACC. Cardiovascular imaging ·Jaydev K. Dave,Valgerdur G. Halldorsdottir,John R. Eisenbrey,Joel S. Raichlen,Ji‐Bin Liu,(unknown),(unknown),Shumin Wang,(unknown),Flemming Forsberg	65
10	Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models 2012 ·Journal of Clinical Epidemiology ·Sanne A. E. Peters,Michiel L. Bots,Hester M. den Ruijter,Mike K. Palmer,Diederick E. Grobbee,John R. Crouse,Daniel H. O’Leary,Gregory W. Evans,Joel S. Raichlen,Karel G.M. Moons,Hendrik Koffijberg	126
11	Lipid Levels After Acute Coronary Syndromes 2008 ·Journal of the American College of Cardiology ·Bertram Pitt,Joseph Loscalzo,J. Ycas,Joel S. Raichlen	128
12	Statin Therapy Alters the Relationship Between Apolipoprotein B and Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol Targets in High-Risk Patients 2008 ·Journal of the American College of Cardiology ·Christie M. Ballantyne,Joel S. Raichlen,Valerie A. Cain	78
13	Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high-resolution magnetic resonance imaging trial 2008 ·American Heart Journal ·Hunter R. Underhill,Chun Yuan,Xue-Qiao Zhao,Larry W. Kraiss,Dennis L. Parker,Tobias Saam,Baocheng Chu,Norihide Takaya,Fei Liu,Nayak L. Polissar,Blažej Neradilek,Joel S. Raichlen,Valerie A. Cain,John C. Waterton,(unknown),Thomas S. Hatsukami	201
14	Abstract 1912: Time Course of Change in Plaque Composition Associated with Rosuvastatin Therapy as Assessed by High-Resolution Magnetic Resonance Imaging 2007 ·Circulation ·Minako Oikawa,Chun Yuan,Hunter R. Underhill,Xue-Qiao Zhao,Larry W. Kraiss,Dennis L. Parker,Tobias Saam,Baocheng Chu,Norihide Takaya,Fei Liu,Nayak L. Polissar,Blažej Neradilek,Joel S. Raichlen,Valerie A. Cain,John C. Waterton,(unknown),Thomas S. Hatsukami	0
15	Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II 2006 ·American Heart Journal ·Christie M. Ballantyne,Marcelo Chiara Bertolami,(unknown),(unknown),Evan A. Stein,Pierre Théroux,Robert Weiss,Valerie A. Cain,Joel S. Raichlen	87
16	Effect of contrast enhancement on measurement of carotid artery intimal medial thickness 2002 ·Journal of the American College of Cardiology ·(unknown),(unknown),(unknown),Philip R. Liebson,Peter Meyer,(unknown),Joel S. Raichlen,Michael H. Davidson,Steven B. Feinstein	2
17	Prognostic significance of ST-segment depression during adenosine perfusion imaging 1995 ·American Heart Journal ·(unknown),Joel S. Raichlen,Sung Min Kim,Charles Intenzo,(unknown),(unknown),Dennis A. Tighe,CHAN H. PARK	26
18	ST-segment depression during adenosine infusion as a predictor of myocardial ischemia 1994 ·American Heart Journal ·(unknown),Joel S. Raichlen,Dennis A. Tighe,James J. Paul,(unknown),Edward K. Chung	27
19	Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the phase III albunex multicenter trial 1993 ·Journal of the American College of Cardiology ·Linda J. Crouse,(unknown),(unknown),Joseph Kisslo,Arthur J. Labovitz,Joel S. Raichlen,Ronald W. Schutz,Pravin M. Shah,Mikel D. Smith	186
20	Dynamic three-dimensional reconstruction of the left ventricle from two-dimensional echocardiograms 1986 ·Journal of the American College of Cardiology ·Joel S. Raichlen,(unknown),Gábor T. Herman,Martin G. St. John Sutton,(unknown)	95

About Joel S. Raichlen

Joel S. Raichlen is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery, having authored 68 papers that have together received 5.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (30 papers), Cardiac Imaging and Diagnostics (19 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.0k citations), Surgery (3.3k citations) and Radiology, Nuclear Medicine and Imaging (1.6k citations). Joel S. Raichlen has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Christie M. Ballantyne, Stephen J. Nicholls, Steven E. Nissen, Peter Libby, Valerie A. Cain, Kathy Wolski, Raimund Erbel, Jean‐Claude Tardif, Michiel L. Bots and Mike K. Palmer. Their work appears in journals such as New England Journal of Medicine, JAMA and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact